C.Q. Pharmaceutical Hits Day Low of CNY 6.09 Amid Price Pressure

C.Q. Pharmaceutical Holding Co., Ltd. experienced a significant decline in its stock price today, dropping by 6.42% and reaching an intraday low of CNY 6.09. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 2.04% during the same period. Over the past week, C.Q. Pharmaceutical has seen a more pronounced downturn, with a 9.33% decrease, while its monthly performance remains slightly positive at 0.66%. However, the company's longer-term performance metrics reveal a mixed picture. Over the past year, the stock has gained 22.65%, outperforming the Shanghai Composite's 20.36% increase. Yet, over three and ten years, the stock has underperformed, with declines of 17.07% and 17.85%, respectively. Financially, C.Q. Pharmaceutical is net-debt free, which is a positive indicator. However, it has faced challenges with profitability, as evidenced by a return on equity of 4.69% and a debt-equity ratio of 2.05. The company’s operating cash flow has also shown weakness, recording a low of CNY -307.72 million. Overall, the stock's current performance reflects ongoing volatility within the pharmaceuticals and biotechnology sector.